Therapeutic Targeting of Tumor-associated Macrophages and Microglia in Glioblastoma
Authors:
- 1 June 2014
- journal article
- Published by Taylor & Francis in Immunotherapy
- Vol. 6 (6) , 663-666
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- CSF-1R inhibition alters macrophage polarization and blocks glioma progressionNature Medicine, 2013
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamicsProceedings of the National Academy of Sciences, 2013
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric AstrocytomasPLOS ONE, 2012
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor responseProceedings of the National Academy of Sciences, 2012
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeJournal of Neuro-Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomasThe Journal of Pathology, 2008
- The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1Neuro-Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005